Within the two days leading experts and specialists from all over Europe will discuss the implementation of recommendations identified by the nanomedicine community that will shape the future of the sector in Europe.
The event takes place in Grenoble, France and is organised by CEA-Leti, a leading French research and technology organisation focused on nanotechnologies and their applications in healthcare.
The event aims to provide further details on the ETPN’s recommendations for nanomedicine under the upcoming Research Framework Programme Horizon 2020, the EU's main instrument for research funding in Europe, launching from 2014-2020.
Patrick Boisseau, chairman of the ETPN, said: “The first line has been crossed with the official renewal of the ETPN as a European Technology Platform, which represents an increasingly key element in the European innovation ecosystem and a main bridge between the community and the European Commission that is needed to implement Horizon 2020.”
He added, “We look forward to welcoming all European stakeholders involved in the nanomedicine field during the ETPN GA at CEA-Leti. Organising our annual event at this widely recognised scientific location will bring the ETPN even closer to the nanomedicine community and will provide participants with the opportunity to visit state-of-the-art facilities on site.”
The event focus on establishing the ETPN’s new action plan with a strong attention on strengthening industry engagement and extending the platform’s community as nanomedical R&D is expected to progress in the upcoming years from the pre-clinical to the clinical testing stage. Furthermore, future milestones will be set for the implementation of the recently released White Paper’s concept elaborated by the NANOMED2020 European consortium to drive innovation across Europe in nanomedicine. The White Paper “Contribution of Nanomedicine to Horizon 2020” can be downloaded on the ETPN website: http://www.etp-nanomedicine.eu/etpn-white-paper-2013.
To support and manage the translation of excellent research into innovative medical products in areas of unmet medical need efficiently, the nanomedicine community strives to set up a Translation Hub as an umbrella of dedicated new infrastructures. Notably, this includes a certain Translational Advisory Board to select, guide, and push forward the top applicable concepts: A novel funding instrument for SMEs, and an EU-NCL infrastructure with the strong involvement of its U.S. counterpart, the Nanotechnology Characterization Laboratory (US-NCL) in Frederick, Maryland.
On October 1, following keynote openings from high-level representatives of the French government and the European Commission, selected experts and leading industry specialists will introduce the latest issues evolving around the nanomedicine ecosystem and value chain.
The ETPN GA preliminary programme and online registration form are available on the ETPN Website: http://www.etp-nanomedicine.eu/ga2013.About ETPN
Wiebke Ehret | idw
Call for Papers – ICNFT 2018, 5th International Conference on New Forming Technology
16.08.2017 | BIAS - Bremer Institut für angewandte Strahltechnik GmbH
Sustainability is the business model of tomorrow
04.08.2017 | Technische Universität Chemnitz
16.08.2017 | Event News
04.08.2017 | Event News
26.07.2017 | Event News
18.08.2017 | Life Sciences
18.08.2017 | Physics and Astronomy
18.08.2017 | Materials Sciences